Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740540 · ClinicalTrials.gov registry record · NA
Implant for Walking After Stroke
A NA study of Stroke and Hemiplegia, sponsored by MetroHealth Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT05740540: Recruiting NA study of Stroke and Hemiplegia, sponsored by MetroHealth Medical Center.
NCT05740540 is a NA study of Stroke and Hemiplegia that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05740540, a NA study of Stroke and Hemiplegia, is actively recruiting participants, sponsored by MetroHealth Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes installing the device and setting the individual up for home use, creating advanced controllers for walking and evaluating the effect of the device over several months.
Primary Outcome
The 10mWT is used to assess walking speed in meters/second (m/s) over a short distance. Gait speed is how we're evaluating whether the advanced controller works better than a simple generic triggering approach.
Conditions Studied
Interventions
- DEVICE IRS-8
- DEVICE IST 12 & IST 16
Study Locations (2)
Ohio
- Louis Stokes Cleveland Veterans Affairs Medical Center - Cleveland
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-05-16 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05740540 shows while recruiting
NCT05740540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which IRS-8 is the first listed.
NCT05740540 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05740540 about?
NCT05740540 is a clinical study titled "Implant for Walking After Stroke". This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller developm...
What is the current status of trial NCT05740540?
This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-05-16. Estimated completion is 2027-06-30.
What conditions does trial NCT05740540 study?
This clinical trial studies the following conditions: Stroke, Hemiplegia, Gait, Hemiplegic.
What interventions are being tested in trial NCT05740540?
The interventions under investigation include: IRS-8 (DEVICE), IST 12 & IST 16 (DEVICE).
Who is sponsoring clinical trial NCT05740540?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05740540 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05740540's enrollment target sits among peer trials
6 433rd of 454 higher than 17 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI